Ateronon

DIETARY_SUPPLEMENT4 trials

Sponsors

Brigham and Women's Hospital, Cambridge University Hospitals NHS Foundation Trust, Omicron Pharmaceuticals

Conditions

AtherosclerosisCarotid Atherosclerotic DiseaseCoronary Heart DiseaseIschemic Heart DiseasePeripheral Vascular DiseaseStrokeTransient Ischemic Attack

Phase 3

Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease

CompletedNCT00939237

Brigham and Women's HospitalCoronary Heart Disease

Start: 2009-07-31End: 2011-05-31Updated: 2014-08-19

Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis

CompletedNCT01287182

Omicron PharmaceuticalsAtherosclerosis

Start: 2011-05-31End: 2011-12-31Updated: 2013-05-21

Unknown Phase

TomVasc - Vascular Effects of Tomato Extract

CompletedNCT01100385

Cambridge University Hospitals NHS Foundation TrustIschemic Heart Disease, Peripheral Vascular Disease, Stroke +1

Start: 2010-02-28End: 2012-05-31Updated: 2015-06-25

Supplementation of Lycopene in Carotid Atheroma

WithdrawnNCT01102504

Cambridge University Hospitals NHS Foundation TrustCarotid Atherosclerotic Disease

Start: 2015-08-31End: 2018-04-30Updated: 2015-04-06

Related Papers

Effects of Oral Lycopene Supplementation on Vascular Function in Patients with Cardiovascular Disease and Healthy Volunteers: A Randomised Controlled Trial

PLoS ONE2014-06-09131 citations